Escherichia coli: a growing problem in early onset neonatal sepsis

Bronwyn Jones1, Kirstie Peake, Arthur J Morris

  • 1National Women's Hospital, Auckland, New Zealand.

Insights

Early-onset Escherichia coli sepsis in newborns is linked to high mortality rates and significant neurodevelopmental impairment in survivors. Amoxicillin resistance is prevalent, but gentamicin resistance remains low in local E. coli isolates.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Early-onset neonatal sepsis poses a significant threat to infant health.
  • Escherichia coli is a common pathogen causing neonatal sepsis.
  • Understanding risk factors and outcomes is crucial for improving neonatal care.

Purpose of the Study:

  • To examine the characteristics, risk factors, and outcomes of early neonatal sepsis caused by Escherichia coli.
  • To assess antenatal antibiotic use.
  • To determine the antimicrobial susceptibility of E. coli isolates.

Main Methods:

  • Retrospective chart review of infants with E. coli-positive blood or cerebrospinal fluid cultures.
  • Data collected from January 1998 to October 2002.
  • Analysis of demographic data, pregnancy complications, birth outcomes, and antimicrobial resistance patterns.

Main Results:

  • Twenty cases of E. coli sepsis identified (19 liveborn, 1 stillborn).
  • High incidence of preterm birth (90%) and pregnancy complications (e.g., preterm rupture of membranes, 50%).
  • Mortality rate was 40% (8/20); 33% of survivors had neurodevelopmental impairment.

Conclusions:

  • Early-onset E. coli sepsis is associated with severe outcomes, including high mortality and neurodevelopmental deficits.
  • High amoxicillin resistance rates were observed in E. coli isolates.
  • Gentamicin resistance was low, suggesting its potential utility in treatment regimens.
Abstract

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...